Expression of Interest (EoI), by eligible industry partners/collaborators is invited by CSIR-Indian Institute of Chemical Biology, Kolkata – 700 032, for co-developing/outright licensing and sale of the technologies for diagnostic kits for detection of Rheumatoid Heart Disease and Visceral Leishmaniasis; Small molecule therapeutics for Autoimmune and inflammatory diseases; NAFLD; Liposomal formulations against Visceral Leishmaniasis and Novel Thermostable Insulin and other novel processes and products.

For further details please visit www.iicb.res.in.

EoI may be submitted to Director, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Kolkata - 700 032 by speed post/registered post. Interest may also be submitted via Email at: director@iicb.res.in

Technologies Available:

• PROTAC Based Technology Targeting degradation of ASK1 Protein as an alternative therapy in NASH

• An improved process for indole-3-carboxylic acid derivatives in the manufacture of TROPISETRON

• Small Molecule Modulators of COP1-ATGL axis

• An easy-to-use point-of-care fluorescence-based system for RNA-based detection of dengue directly from serum samples

• Recombinant Construct Based Assay for Screening Drugs Against Host Proteases Helping In Virus Entry

• Antibacterial Hemostatic Dressing- Stop Bleeding & Prevent Bacterial Infection

• Improved synthetic process for the synthesis of 2-(4-chlorophenyl)-2-hydroxy-N-(3-methoxy-4-(prop-2-yn-1-yloxy)phenethyl)acetamide, a key intermediate for the synthesis of Mandipropamid

• Detection system for Alzheimer’s disease using brain structural and/or functional magnetic resonance image processing and machine learning techniques

• A Novel Liposomal Amphotericin B (Cat-LAmB) for Treatment of Visceral Leishmaniasis and Fungal Infections

• Rapid Diagnostic test for detection of Visceral Leishmaniasis (Kala-azar): Novel Liposomal Amphotericin B for Treatment of Kala-azar and fungal infections

• Dihydrofolate formulation for dietary supplementation as an effective nutraceuticalsupplement and method of preparation thereof

• 3-indolyl Furanoids As Inhibitors of Matrix Metalloproteinase-9 for Prevention of Gastric Ulcer and Other Inflammatory Diseases

• New Process for Manufacturing TROPISETRON

• Novel Amphotericin B Liposomal formulation against Leishmaina

• Novel Anti-inflammatory Agents against Gastric Ulcer

• Novel DNA Vaccine Formulation against Leishmania

• Novel Liposomal Formulations against Cancer

• Novel Paromomycin Liposomal Formulation against Leishmania

• Novel Thermostable insulin formulation

• Potent TLR9-selective and TLR9and7 dual antagonists

• Rapid Tests for Diagnosis of Human and Canine Visceral Leishmaniasis (VL) and Post Kala-azar Dermal Leishmaniasis (PKDL)

• An easy-to-use point-of-care system for RNA-based detection of Dengue

• Biomarker for Rheumatic Heart Disease (RHD)

• An improved process for the manufacture of Tilorone and its salts

Interested parties are requested to include Annexure I with their Expression of Interest (EoI).